Deep Dive

Digital
How digital could transform stakeholder engagement

How digital could transform stakeholder engagement

Digital may be upending every aspect of the pharma industry, but many would assume that engagement activities like advisory boards, working groups and medical education will remain a bastio

Digital
The future of R&D innovation

The future of R&D innovation

Alexander Gray and Mike Rea from IDEA Pharma explain why the current pharma R&D model is broken, and how it’s hindering commercialisation for companies across the industry

Digital
China in the fast lane

China in the fast lane

Brett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest emerging market

Digital
Developing with start-up DNA

Developing with start-up DNA

As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.

Digital
Deep Dive Access and Commercialisation

Deep Dive: Access and Commercialisation

In this issue of Deep Dive we explore the ever present issues of market access and commercialisation, analysing recent changes in China, England and the US and asking how pharma can work wi

Digital
Deep Dive Disruptive Technologies in pharma

Deep Dive: Disruptive Technologies

In the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they're changing medicine, research and development, and healthcare, and how the pharmaceutical i